IL6 and obesity disorder: Contraction-induced myokines (e.g., IL-6) can further augment insulin signaling and exert anti-inflammatory effects (70, 82–84), which is pertinent for individuals with obesity who commonly exhibit low-grade inflammation and insulin resistance (85, 86).